Create a free account to see ACCE Scores
Sign up for free to unlock scores, score breakdowns, and stock analysis.
OBIO
↓ PDF (Pro)Orchestra BioMed Holdings Inc. Ordinary Shares
HealthcareBiotechnologyUnited StatesNASDAQ
$4.10
+2.12%today
MKT CAP
$245M
-8.1% · 1Y
Earnings History
-1.7%
+1.4%
+6.7%
+168.7%
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Analyst Targets
Current price
$4.10
Low
$9.00
Analyst Mean
$12.43
High
$20.00
7 analystsStrong Buy
Full Financials
Trailing P/E-
Forward P/E-2.3x
EV/EBITDA-
Price/Sales-
Dividend Yield-
Revenue Growth YoY-
Earnings Growth YoY-
Revenue Growth QoQ+3490.8%
5y Revenue CAGR+111.6%
5y Earnings CAGR-
Gross Margin-
Operating Margin-
Net Margin-
ROE-
Debt / Equity-
Free Cash Flow-
Insider Ownership26.2%
Institutional Ownership39.5%
Short % of Float2.28%
Days to Cover4.8d
1 Week+2.1%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Insider Transactions
| Filer | Role | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| RTW INVESTMENTS, L.P. | Beneficial Owner of more than 10% of a Class of Security | Sale | 32 | $4.13 | $0.00M | 2026-04-27 |
| RTW INVESTMENTS, L.P. | Beneficial Owner of more than 10% of a Class of Security | Conversion | 1,250,032 | $0.00 | $0.00M | 2026-04-27 |
| HOCHMAN DAVID P | Chief Executive Officer | Buy | 10,000 | $4.29 | $0.04M | 2026-03-13 |
| SHERMAN DARREN | President | Stock | 397,000 | $0.00 | $0.00M | 2026-02-12 |
| TAYLOR ANDREW LAWRENCE | Chief Financial Officer | Stock | 181,000 | $0.00 | $0.00M | 2026-02-12 |
Top Holders
| Holder | Type | % Held | Value | Δ Shares | As of |
|---|---|---|---|---|---|
| RTW Investments LP | institution | 13.87% | $0.03B | +0.00% | 2025-12-31 |
| Perceptive Advisors Llc | institution | 8.56% | $0.02B | -3.12% | 2025-12-31 |
| Vanguard Group Inc | institution | 2.68% | $0.01B | +8.28% | 2025-12-31 |
| Alyeska Investment Group, L.p. | institution | 1.67% | $0.00B | -26.77% | 2025-12-31 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | fund | 1.57% | $0.00B | +3.58% | 2025-12-31 |
| Blackrock Inc. | institution | 1.05% | $0.00B | -5.03% | 2025-12-31 |
| Affinity Asset Advisors, Llc | institution | 0.96% | $0.00B | -21.24% | 2025-12-31 |
| Geode Capital Management, LLC | institution | 0.79% | $0.00B | +22.38% | 2025-12-31 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | fund | 0.66% | $0.00B | +20.88% | 2025-12-31 |
| Price (T.Rowe) Associates Inc | institution | 0.61% | $0.00B | -13.51% | 2025-12-31 |
| Charles Schwab Investment Management, Inc. | institution | 0.44% | $0.00B | +46.19% | 2025-12-31 |
| T. Rowe Price Health Sciences Fund, Inc. | fund | 0.43% | $0.00B | -8.07% | 2025-12-31 |
| Knott David M., Jr. | institution | 0.42% | $0.00B | +28.21% | 2025-12-31 |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | fund | 0.34% | $0.00B | -0.36% | 2026-02-28 |
| BlackRock Funds-BlackRock Health Sciences Opportunities Portfolio | fund | 0.34% | $0.00B | -2.12% | 2026-02-28 |
| SCHWAB STRATEGIC TRUST-Schwab U.S. Small-Cap ETF | fund | 0.30% | $0.00B | +1.07% | 2026-02-28 |
| iShares Trust-iShares Micro-Cap ETF | fund | 0.17% | $0.00B | -5.27% | 2026-03-31 |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | fund | 0.12% | $0.00B | +0.00% | 2026-02-28 |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | fund | 0.10% | $0.00B | +0.00% | 2026-02-28 |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | fund | 0.08% | $0.00B | +0.00% | 2026-02-28 |
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Recent Alerts
No alerts yet for OBIO.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.